EQUITY RESEARCH MEMO

Melzi Surgical

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Melzi Surgical, a San Francisco-based medical device company founded in 2019, has developed the Sharps Finder, an advanced surgical tool designed to quickly locate lost sharps and prevent retained surgical items. The device aims to reduce X-ray exposure for both patients and staff while minimizing the risk of prolonged surgeries caused by miscounts. By providing surgeons with an efficient and effective solution, Melzi Surgical addresses a critical patient safety issue in operating rooms. The company is privately held and operates in the medical devices sector, with its product poised to improve surgical workflow and reduce reliance on intraoperative X-rays. While limited financial and operational data are publicly available, the clear clinical need and innovative approach position the company for potential adoption in hospitals seeking to enhance safety and efficiency. The executive summary underscores Melzi Surgical's focus on a niche but high-impact problem, leveraging technology to solve a persistent challenge in surgery. With a target market of surgical centers and hospitals, the company's success hinges on regulatory clearance and market penetration. Given the absence of disclosed funding or revenue, the conviction score is moderate, reflecting early-stage uncertainty but promising clinical utility.

Upcoming Catalysts (preview)

  • Q4 2026FDA 510(k) Clearance for Sharps Finder75% success
  • Q1 2027First Hospital Pilot or Commercial Sale50% success
  • Q2 2027Partnership with Major Surgical Supply Distributor40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)